Gujarat Themis Biosyn

Gujarat Themis Biosyn Limited is a key contributor to the nation's healthcare system by providing best-in-class products in the biotechnology and pharmaceutical industries. The company's vision is to grow significantly by capitalizing on market opportunities, both domestically and globally, to establish itself as a key player in its field. Its core mission is to consistently provide reliable, safe, and affordable products that help people around the world to live healthier lives. The company currently manufactures Rifamycin S and Rifamycin O, which are intermediates for producing antibiotics used to treat various bacterial infections like tuberculosis and traveler's diarrhea. A primary factor that distinguishes the company is its deep domain expertise in fermentation, setting it apart from other competitors in the market. Financially, the company achieved a Profit After Tax of ₹59.16 Crores for the fiscal year 2024, which represents an increase of 2.06% over the previous year.;